IPO registrations (S-1, F-1) · Registrants

Sienna Biopharmaceuticals, Inc.

SEC CIK
1656328 · filings on EDGAR ↗
Former names
Sienna Labs, Inc. (2015–2015)
Registration
Form S-1, first filed 2017-07-03, last 2017-07-24; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2017-07-27; declared effective 2017-07-26
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
30699 RUSSELL RANCH ROAD, SUITE 140, Westlake Village, CA 91362
EIN
27-3364627
EDGAR entity type
operating
Insiders and CEO pay
Sienna Biopharmaceuticals, Inc. on the corporate pages

Offering terms

Proposed price range
$14.00–$16.00 per share (S-1/A filed 2017-07-24)
Final price
$15.00 per share, within the range (424B4 filed 2017-07-27, an initial public offering)
Shares sold
4,333,333
Gross proceeds
$64,999,995 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol SNNA
Lead underwriters
J.P. Morgan
Syndicate
Cowen; BMO Capital Markets

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2017-07-03S-1S-1 (registration)Sienna Biopharmaceuticals, Inc.0001193125-17-221074 ↗
2017-07-17S-1/AS-1/A (amendment)Sienna Biopharmaceuticals, Inc.0001193125-17-228984 ↗
2017-07-24S-1/AS-1/A (amendment)Sienna Biopharmaceuticals, Inc.0000950123-17-006251 ↗
2017-07-26EFFECTEFFECT (declared effective)Sienna Biopharmaceuticals, Inc.9999999995-17-001925 ↗
2017-07-27424B4424B4 (final prospectus)Sienna Biopharmaceuticals, Inc.0001193125-17-238703 ↗
2018-08-14EFFECTEFFECT (declared effective)Sienna Biopharmaceuticals, Inc.9999999995-18-002100 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2017-07-24S-1/Aregistration statement$14.00–$16.004,333,333-Nasdaq SNNA3primary document; range, shares headline, cover names 3document ↗
2017-07-27424B4final prospectus$15.004,333,333$64,999,995Nasdaq SNNA3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Andrews Timothy K.OfficerGeneral Counsel & Secretary72017–2019
ARCH Venture Fund VIII, L.P.TenPercentOwner32017–2019
ARCH Venture Fund VIII Overage, L.P.TenPercentOwner32017–2019
ARCH Venture Partners VIII, LLCTenPercentOwner42017–2019
ARCH Venture Partners VIII, L.P.TenPercentOwner32017–2019
Beddingfield III FrederickDirector,OfficerPresident & CEO92017–2019
Burow KristinaDirector; Director,TenPercentOwner62017–2019
BYBEE CLINTONTenPercentOwner32017–2019
CRANDELL KEITHTenPercentOwner42017–2019
FENTON DENNIS MDirector42017–2019
Harris ToddDirector; Director,OfficerHead of Corporate Development112017–2019
Leonard Keith RDirector62017–2019person page Fuzzy
Lizzul Paul F.OfficerChief Medical Officer72017–2019
MAST ERLE TDirector32017–2018
MORE ROBERT JDirector72017–2019
NELSEN ROBERTDirector,TenPercentOwner; TenPercentOwner62017–2019
PETERSON RICHARD DOfficerChief Financial Officer32017
Stroehmann DianeOfficerSee Remarks62017–2019
Smither John WOfficerChief Financial Officer42018–2019
Hindman James M.Director32018–2019
ARCH Venture Fund X Overage, L.P.TenPercentOwner12019
ARCH Venture Partners X, LLCTenPercentOwner12019
ARCH Venture Partners X Overage, L.P.TenPercentOwner12019
GILLIS STEVENTenPercentOwner12019
Azoy AlexanderOfficerChief Financial Officer52019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-05-15Sienna Biopharmaceuticals, Inc.Biotechnology$40,500,000$40,471,910291
2015-10-20Sienna Biopharmaceuticals, Inc.Biotechnology$50,000,000$46,630,453912

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorSIENNA BIOPHARMACEUTICALS, INC.CAForm 5500 (employee benefit plans)name and state
Form D issuerSienna Biopharmaceuticals, Inc.CAForm D private offeringsCIK (EXACT)
Patent assigneeSienna Biopharmaceuticals, Inc.CAPatents (USPTO)name and state
SEC filerSienna Biopharmaceuticals, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerSienna Biopharmaceuticals, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorSIENNA BIOPHARMACEUTICALS, INC.EIN (EXACT)
Person pageKeith R LeonardPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health